Recent studies also show that MELK is frequently elevated in multiple human tumors such as prostate cancer [17], breast cancer [18], glioblastoma multiforme [19] and medulloblastoma [20], and is correlated with a poor prognosis [21]. This evidence concerns the gene MELK and prostate cancer.